Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

BBT-176

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Bridge Biotherap

Drug class:

EGFR inhibitor, Tyrosine kinase inhibitor

Related drugs:

‹

Tyrosine Kinase inhibitors (0)

cetuximab (347)

osimertinib (301)

erlotinib (235)

gefitinib (194)

panitumumab (123)

lapatinib (107)

neratinib (102)

brigatinib (50)

aumolertinib (39)

amivantamab-vmjw (25)

firmonertinib (14)

mobocertinib (12)

lazertinib (12)

tarloxotinib bromide (7)

nimotuzumab (6)

rociletinib (5)

tomuzotuximab (4)

necitumumab (3)

befotertinib (3)

ABP 494 (cetuximab biosimilar) (1)

BAY 2927088 (1)

Compound 6a (1)

abivertinib (1)

STI-001 (cetuximab biosimilar) (0)

antroquinonol (0)

zalutumumab (0)

JNJ-26483327 (0)

PF-08046052 (0)

rindopepimut (0)

Undisclosed EGFR inhibitor (0)

cetuximab biosimilar (0)

PF-06747775 (0)

JNJ-64041757 (0)

Tyrosine Kinase inhibitors (0)

›

EGFR exon 19 deletion	Non Small Cell Lung Cancer	EGFR exon 19 deletion	Non Small Cell Lung Cancer	BBT-176 Sensitive: C2 – Inclusion Criteria BBT-176 Sensitive : C2	BBT-176 Sensitive: C2 – Inclusion Criteria BBT-176 Sensitive : C2
EGFR C797S	Non Small Cell Lung Cancer	EGFR C797S	Non Small Cell Lung Cancer	BBT-176 Sensitive: C3 – Early Trials BBT-176 Sensitive : C3	BBT-176 Sensitive: C3 – Early Trials BBT-176 Sensitive : C3
EGFR T790M	Non Small Cell Lung Cancer	EGFR T790M	Non Small Cell Lung Cancer	BBT-176 Sensitive: C3 – Early Trials BBT-176 Sensitive : C3	BBT-176 Sensitive: C3 – Early Trials BBT-176 Sensitive : C3
EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer	EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer	BBT-176 Sensitive: C3 – Early Trials BBT-176 Sensitive : C3	BBT-176 Sensitive: C3 – Early Trials BBT-176 Sensitive : C3
EGFR mutation	Non Small Cell Lung Cancer	EGFR mutation	Non Small Cell Lung Cancer	BBT-176 Sensitive: C3 – Early Trials BBT-176 Sensitive : C3	BBT-176 Sensitive: C3 – Early Trials BBT-176 Sensitive : C3